Právní předpis byl sestaven k datu 08.04.2026.
Zobrazené znění právního předpisu je účinné od 07.12.2020.
Sdělení o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2021
509/2020 Sb.
509
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx dne 18. listopadu 2020
x xxxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxxxx, xxxxxxxx a xxxxxxxxx xxxxxxxx xxx xxx 2021
Xxxxxxxxxxxx xxxxxxxxxxxxx podle §80 xxxx. 1 xxxx. x) zákona x. 258/2000 Xx., x ochraně veřejného xxxxxx a x xxxxx některých souvisejících xxxxxx, ve xxxxx xxxxxxxxxx xxxxxxxx, xxxxxxx xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx komise xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx pro rok 2021:
1. Xxxxxxxxx složení xxxxxxxxxx xxxxx pro xxxxxxxxxx xxxxxxxx
1x) xxxxxxxxxxx xxxxxxxx xxxxx proti xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx forma), xxxxxx xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx x (XXxXXxxXXXXXX):
Xx xxxxxxxxxxxx 1 dávka (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (IU)
Tetani anatoxinum1 xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx pertussis:
Pertussis xxxxxxxxxx (PT)1 25 xxxxxxxxxx
Xxxxxxxxx haemagglutininum xxxxxxxxxxxx (XXX)1 25 xxxxxxxxxx
Xxxxxxxxxxx (XXX)1 8 mikrogramů
Antigenum xxxxxxxxx xxxxxxxxxxx X (XXx)2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx inactivatum (IPV)
typus 1 (xxxx Mahoney)4 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (kmen XXX-1)4 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx b xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phosphas) 10 xxxxxxxxxx
xxxx. cum anatox. xxxxxxxx xxxx xxxxx xxxxxxx xxxxxxxxx 25 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxx hlinitý, hydratovaný (Xx(XX)3) 0,5 xxxxxxxxx Xx3+
2 xxxxxxxx xxxxxxxxxxxxx XXX technologií xx xxxxxxx xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx xxxxxxxxxx)
3 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (XxXX4) 0,32 xxxxxxxxx Xx3+
4 xxxxxxxxx xx XXXX xxxxxxx
XXXX
1xx) xxxxxxxxxxx xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), tetanu, xxxxxx přenosné obrně (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum ne xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxx xxxxxxxxxx xx méně xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)2
Xxxxxxxx Bordetelly xxxxxxxxx
Xxxxxxxxx anatoxinum 25 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (xxxxxxxxxxxx)3
xxxxx 1 (Mahoney) 40 X xxxxxxxx antigenu4
typus 2 (MEF-1) 8 X jednotek xxxxxxxx4
xxxxx 3 (Xxxxxxx) 32 X jednotek xxxxxxxx4
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X5 10 mikrogramů
Polyribosylribitoli xxxxxxxx xxxxxxxxxx influenzae X 12 xxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx)
xxxxxxxxx xxx tetani anatoxinum 22-36 mikrogramů
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx (0,6 xx Xx3+)
2 jako xxxxxx xxx xxxxxxxxxxxxx (x = 0,95)
3 xxxxxxxxx xx XXXX xxxxxxx
4 xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx stanovené xxxxxxx xxxxxxxxxxxxxx metodou
5 vyrobeno xxxxxxxxxxxxx DNA xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Xxxxxxxxx xxxxxxxxxx
XXXX
1xx) Xxxxxxx xxxxx xxxxxxxx, xxxxxx, xxxxxxx (xxxxxxxxx xxxxxxxxxx), xxxxxxxxxx X (xXXX), xxxxxxxxxxxxxx (xxxxxxxxxxxx) a xxxxxxxxxxx xxxxxxx xxxxx Xxxxxxxxxxx xxxx x (xxxxxxxxxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 xx xxxx xxx 20 XX
Xxxxxx anatoxinum1 xx méně xxx 40 XX
Xxxxxxxx Bordetellae xxxxxxxx1
Xxxxxxxxx anatoxinum (PT) 20 mikrogramů
Haemagglutinium xxxxxxxxxxxx (XXX) 20 mikrogramů
Pertactinum (XXX) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (XXX) 5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (inactivatum)4
Typus 1 (Xxxxxxx) 40 X xxxxxxxx xxxxxxxx5
Xxxxx 2 (XXX-1) 8 X xxxxxxxx xxxxxxxx5
Xxxxx 3 (Xxxxxxx) 32 X xxxxxxxx antigenu5
Polysaccharidi Xxxxxxxxxx xxxxxxxxxx xxxxx x
(Xxxxxxxxxxxxxxxxxxx xxxxxxxx) 3 xxxxxxxxxx xxxxxxxxxx xxx proteinům xxxxxxxxxxxx xxxxx x2 50 xxxxxxxxxx
1 adsorbováno xx xxxxxxxxxxx xxxxxxx (0,17 xx Xx3+)
2 xxxxxxxxxxx xx hydratovaný xxxxxxxx xxxxxxx sulfát (0,15 xx Al3+)
3 xxxxxxxx rekombinantní XXX xxxxxxxxxxx v xxxxxxxxxxxx xxxxxxx Xxxxxxxxxxxxx xxxxxxxxxx
4 xxxxxxxxx xx Vero xxxxxxx
5 xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx.
1x) xxxxxxxx xxxxx proti xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx (XXxX):
Xxxxx xxxxx (0,5 xx) obsahuje xxxx xxxxxx xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 IU
Tetani xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (XX) 25 xxxxxxxxxx
Xxxxxxxxx haemaglutininum xxxxxxxxxxxx* (FHA) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69xX) 8 xxxxxxxxxx
* adsorbováno xx xxxxxxxx hlinitý xxxxxx: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx xxxxx (acelulární) se xxxxxxxx obsahem xxxxxxxx (Xxxx)
Xxxxx dávka (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx - Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxx xxxxxxxxxx - Xxxxxxxxx 20 IU* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx na xxxxxxxxxxx hlinitý - 1,5 mg (0,33 xx xxxxxxx)
* Xxxx xxxxxx xxxxxxx intervalu xxxxxxxxxxxxx (p = 0,95) xxxxxxxx xxxxxx xxxxx testu popsaného x Xxxxxxxxx xxxxxxxx.
XXXX
1xx) Xxxxxxxx xxxxx proti xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) se sníženým xxxxxxx antigenů (Xxxx)
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 xx xxxx xxx 2 xxxxxxxxxxx jednotky (IU) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 xx xxxx xxx 20 mezinárodních xxxxxxxx (XX) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx anatoxinum1 8 mikrogramů
Pertussis haemagglutinum xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxx xxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx xx hydratovaný hydroxid xxxxxxx (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ x xxxxxxxxxxx hlinitý (AlPO4) 0,2 xxxxxxxxx Xx3+
1x) xxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx b:
Jedna xxxxx lyofilizované xxxxxxx xxxxxxxx:
Xxxxxxxxxxxxxxx Xxx xxxxxxxxxxx (10 xxxxxxxxxx) xxx Xxxxxxxxx xxxxxxxx (přibližně 25 mikrogramů).
1d) očkovací xxxxx xxxxx xxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxx xxxxxxxxxx - xxx. 40 xxxxxxxxxxxxx xxxxxxxx
1x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X x xxxxxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx tegiminis xxxxxxxxxxx X - 10 xxxxxxxxxx
1x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X x xxxxxxx xxxxxxx
Xxxxx xxxxx obsahuje:
Antigenum xxxxxxxxx hepatitidis B - 20 xxxxxxxxxx
1x) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx obsahuje:
Morbillorum xxxxx attenuatum1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx attenuatum1 (XXX 4385) xxx. 103,7 xxxxxxxx dávka xxx buněčnou kulturu503
Rubeolae xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx lidských xxxxxxxxxxx xxxxxxx (MRC-5)
3 50 % xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
1xx) xxxxxxxx xxxxx xxxxx spalničkám, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 ml):
Virus xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Enders’ Edmonston) xx méně xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (kmen Xxxxx XxxxXX, hladina X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Xxxxxx RA 27/3) xx méně xxx 1x103 CCID50*
* 50 % infekční xxxxx xxxxxxx kultury
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx.
2 vyrobeno xx lidských xxxxxxxxxxx xxxxxxxx WI-38 xxxxxxxxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxx xxxxx x inaktivované xxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 1 (Xxxxxxx) … 40 xxxxxxxxxxx X xxxxxxxx*
Xxxxx xxxxxxxxxxxxx xxxxxxxxxxx xxxxx 2 (XXX-1) ......… 8 antigenních X xxxxxxxx*
Xxxxx poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ...… 32 xxxxxxxxxxx X jednotek*
* nebo xxxxxxxx ekvivalentních antigenů xxxxxxxxx pomocí xxxxxx xxxxxxxxxxxxx xxxxxx.
1xx) xxxxxxxx xxxxx xxxxxxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 11 2,2 µx
Xxxxxxxxxxxx pneumoniae polysaccharidum xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 41 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx pneumoniae polysaccharidum xxxxxxxxx 6X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6X1 4,4 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 7X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 141 2,2 µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 18X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 23X1 2,2 µx
1 Xxxxxxxxxx s xxxxxx xxxxxxxxx XXX197, xxxxxxxxxx xx xxxxxxxxxxx xxxxxxx.
Xxxxx xxxxx (0,5xx) xxxxxxxx xxxxxxxxx 32 µx xxxxxxx xxxxxxxx XXX197 x 0,125 xx hliníku.
1i) xxxxxxxx xxxxx proti xxxxxxx, xxxxxxxx xxxxx (acelulární xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 - ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx xxxxxxxxxx1 - xx méně xxx 20 xxxxxxxxxxxxx xxxxxxxx (XX) (5 Lf)
Bordetellae xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 - 8 mikrogramů
Pertussis xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 mikrogramů
Pertaktin1 2,5 xxxxxxxxxx
Xxxxx poliomyelitidis inactivatum:
typus 1 (xxxx Xxxxxxx)2 - 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx MEF-1)2 - 8 X xxxxxxxx xxxxxxxx
xxxxx 3 (kmen Xxxxxxx)2 - 32 X xxxxxxxx xxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ x fosforečnan hlinitý (XxXX4) 0,2 xxxxxxxxx Xx3+
2 xxxxxxxxx xx XXXX buňkách
NEBO
1ia) xxxxxxxx xxxxx xxxxx záškrtu, xxxxxxxx xxxxx (acelulární xxxxx), tetanu, dětské xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx xxxxxxxxx 2 XX* (2,5 Xx)
Xxxxxx anatoxinum xxxxxxxxx 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 et 3 5 mikrogramů
Virus xxxxxxxxxxxxxxx (xxxxxxxxxxx)**
xxxxx 1 40 X xxxxxxxx xxxxxxxx
xxxxx 2 8 X jednotek antigenu
typus 3 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx 1,5 xx (0,33 xx xxxxxxx)
* Jako xxxxxx xxxxxxx intervalu xxxxxxxxxxxxx (x = 0,95) xxxxxxxx měřené podle xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx.
** Xxxxxxxxxxx xx Xxxx xxxxxxx.
1x) xxxxxxxx látka xxxxx xxxxxxxxxxx (XXX xxxxxxx)
1x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X xxx xxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx xxxxx (0,5 xx) xxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx B1,2,3 - 20 xxxxxxxxxx
1 xxxxxxxxxx xx AS04C obsahující: - 3-X-xxxxxx-4'-xxxxxxxxxxxx-xxxxx X (XXX)2 50 xxxxxxxxxx
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (celkem 0,5 xxxxxxxxx Xx3+)
3 xxxxxxxx xx kultuře kvasinkových xxxxx (Xxxxxxxxxxxxx xxxxxxxxxx) xxxxxxxxxxxxx XXX xxxxxxxxxxx.
2. Xxxxxxxxx složení očkovacích xxxxx xxx xxxxxxxx xxxxxxxx
2x) xxxxxxxx látka xxxxx xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx hepatitidis X - 20 xxxxxxxxxx
2x) xxxxxxxx látka xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx proti xxxxxx xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx obsahuje:
Hepatitis A xxxxx inactivatum
2d) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (RIT 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
Rubeolae virus xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 pomnoženo xx xxxxxxxx diploidních xxxxxxx (XXX-5)
3 50 % xxxxxxxx dávka tkáňové xxxxxxx
XXXX
2xx) xxxxxxxx látka xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám
Po xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx morbillorum1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Xxxxxxxxx) ne xxxx xxx 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Jeryl Xxxx™, xxxxxxx X) xx méně než 12,5x103 CCID50*
Virus xxxxxxxx2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx méně než 1x103 XXXX50*
* 50 % infekční xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 fibroblastech
3. Xxxxxxxxx xxxxxxx očkovacích látek xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx proti xxxxxx hepatitidě X xx xxxxxxx xxx xxxxxxx:
Xxxxxxxxx X xxxxx xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xx formuli xxx děti:
Virus xxxxxxxxx X inactivatum
3c) xxxxxxxx xxxxx proti xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxx:
Xxxxx xxxxx obsahuje:
Morbillorum xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 infekční xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxxxxx xxxxx attenuatum1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx kulturu503
Rubeolae virus xxxxxxxxxx2 (Xxxxxx RA 27/3) min. 103,0 xxxxxxxx dávka xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx buňkách xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx buňkách (XXX-5)
3 50 % xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
3xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, příušnicím x zarděnkám
Po xxxxxxxxxx xxxxxxxx jedna xxxxx (0,5 ml):
Virus morbillorum1 xxxxx attenuatum (kmen Xxxxxx’ Xxxxxxxxx) ne xxxx xxx 1x103 XXXX50*
Xxxxx parotitidis1 xxxxx xxxxxxxxxx (xxxx Xxxxx XxxxXX, hladina B) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx rubeolae2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50 % infekční xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxxx XX-38 xxxxxxxxxxxxx.
Xxxxxxx:
xxx. XXXx. Xxxxxx, Xx.X., x. x.
Xxxxxxxxx
Xxxxxx předpis x. 509/2020 Xx. xxxxx xxxxxxxxx dnem 7.12.2020.
Xx xxx xxxxxxxx právní xxxxxxx nebyl měněn xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx xxxxxxxx xxxxxxxx v xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx derogační xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.